|
Match
|
Document |
Document Title |
|
|
US20120009133 |
POLY (NON-CONJUGATED DIENE) BASED SUNSCREENS
A poly(non-conjugated diene) based sunscreen has a plurality of repeating units where each repeating unit has at least one UV absorbing chromophore that is situated between and connected by chains...
|
|
|
US20130096322 |
METHOD OF BIOBASED CHEMICAL PRODUCTION FROM CRUDE BIOGLYCERIN OF RECYCLED OIL, GREASE, AND FAT ORIGIN
A method of production of value-added, biobased chemicals, derivative products, and/or purified glycerin from bioglycerin of recycled oil, grease, and/or fat origin is described herein. A method of...
|
|
|
US20120220655 |
CRYSTALLINE FORMS OF FESOTERODINE FUMARATE AND FESOTERODINE BASE
Polymorphically pure crystalline forms of fesoterodine fumarate and fesoterodine base are described and characterized.
|
|
|
US20120282200 |
UV ABSORBING DENTRITIC POLYETHER PREPARED BY POLYMERIZATION OF OXETANES
The present invention relates to a polymer comprising a hyperbranched dendritic polyether backbone covalently bonded via an oxygen bridge to at least one UV absorbing chromophore characterized in...
|
|
|
US20110020424 |
USE OF THE IRRITATING PRINCIPAL OLEOCANTHAL IN OLIVE OIL, AS WELL AS STRUCTURALLY AND FUNCTIONALLY SIMILAR COMPOUNDS
The invention provides oleocanthal analogs and methods of using oleocanthals in various formulations including, food additives; pharmaceuticals; cosmetics; animal repellants; and discovery tools...
|
|
|
US20130142834 |
LOCAL DELIVERY OF DRUGS FROM SELF ASSEMBLED COATINGS
The invention relates to oligofluorinated coatings and their use in drag delivery The oligofluorinated coatings are compositions comprising formula (XVII). These coatings are used in a method of...
|
|
|
US20120219538 |
STABILIZED PROTEIN FORMULATIONS AND USE THEREOF
The present invention is directed to stable protein formulations, related methods and uses thereof. In particular, the invention relates to a method of stabilizing therapeutic proteins in aqueous...
|
|
|
US20130072559 |
RETINAL DERIVATIVES AND METHODS FOR THE USE THEREOF FOR THE TREATMENT OF VISUAL DISORDERS
Compositions of and methods for using synthetic retinal derivatives as retinoid replacements and opsin agonists are provided.
|
|
|
US20110086818 |
METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS
The invention features methods, compositions, and kits for selective inhibition of pain-and itch sensing neurons (nociceptors and pruriceptors) by drug molecules of small molecule weight, while...
|
|
|
US20110301288 |
THIOIC ACIDS AS BUILDING BLOCK FOR POLYTHIOESTERS
The present invention relates to thioic acids according to formula (II) suitable as building block for polythioesters; Wherein X is O, N or S and whereby R1 is chosen from (—CH2—)2, —CH...
|
|
|
US20130184487 |
Method to produce a stable dry ionic-bonded creatine alpha ketoglutarate of high oral absorbability
The invention provides a method to produce a stable, ionic-bonded, dry creatine-α-ketoglutarate product at a molar ratio of about 2:1. The product is stable at room temperature when kept dry for ...
|
|
|
US20080188556 |
Water-Soluble Prodrugs of Florfenicol and its Analogs
The present invention discloses certain novel prodrugs of florfenicol and/or of florfenicol analogs, including prodrugs of salts pharmaceutically acceptable salts of florfenicol and its analogs,...
|
|
|
US20080139831 |
Water Tolerant Emulsion Stabilizers
An emulsion stabilizer is disclosed having a water tolerance value of between more than about 1.0 and equal or less than about 11.0.
|
|
|
US20110110914 |
METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS
Methods and formulations for treating oncological disorders in humans using epimetabolic shifters, multidimensional intracellular molecules or environmental influencers are described.
|
|
|
US20120178704 |
PREVENTION AND TREATMENT OF COLON CANCER
Stilbene compounds for the prevention and treatment of colon cancer or colon inflammation and methods of using same are provided.
|
|
|
US20110147986 |
Oxygen Resistant Organic Peroxides for Reticulation/Cure and Their Use in the Process of Continuous Vulcanization in Hot Air Tunnel
This application refers to Organic Peroxides of the Dialcyl, Perester, Perketal, and Dialkyl classes, which were modified to resist to oxygen, destined to be used in the process of production of...
|
|
|
US20120148690 |
SKIN BARRIER FUNCTION RECOVERY ACCELERATOR
A novel skin barrier function recovery acceleration method and accelerator are provided. The present invention provides a skin barrier function recovery accelerator that comprises a TRPA1 agonist...
|
|
|
US20100307378 |
CARBAMATE-METHACRYLATE MONOMERS AND THEIR USE IN DENTAL APPLICATIONS
The present invention relates, generally, to monomers containing carbamate-methacrylates or derivatives of carbamate-methacrylates, processes for making the monomers, and compositions comprising...
|
|
|
US20120108844 |
METHOD OF MEASURING ENTRY OF WATER INTO PHOSGENE-CONDUCTING PLANTS
The invention relates to a method of measuring entry of water and resulting corrosion in plants for producing isocyanates by reacting phosgene with one or more primary amines in a solvent. The...
|
|
|
US20100092420 |
Preservative Systems Comprising Cationic Surfactants
Preservative systems on the basis of cationic surfactants are known i n the art, a typical example of such cationic surfactants is the ethyl ester of the lauramide of arginine monohydrochloride...
|
|
|
US20110319516 |
RELEASE AGENT PARTITION CONTROL IN IMPRINT LITHOGRAPHY
Release agents with increased affinity toward nano-imprint lithography template surfaces interact strongly with the template during separation of the template from the solidified resist in a...
|
|
|
US20110020251 |
Ultraviolet-Absorbing Compounds
Disclosed are novel ultraviolet-absorbing compounds produced by two embodiments. By a first embodiment, the ultraviolet-absorbing compound is derived from at a first reactant being a UV absorber...
|
|
|
US20120156255 |
DRUG ELUTING PATCH FOR THE TREATMENT OF LOCALIZED TISSUE DISEASE OR DEFECT
A polymeric matrix for delivery of an HMG CoA reductase inhibitor such as a statin to tissue such as cardiac tissue in need thereof for the treatment or prevention of a disease or defect such as...
|
|
|
US20130338089 |
METHODS AND COMPOUNDS FOR MODULATING THE SECRETION OR EXPRESSION OF ADHESION PROTEINS OR ANGIOPOIETINS OF CELLS
This invention provides methods, processes, compounds and compositions for modulating the gene expression or secretion of adhesion proteins, angiopoietins or their receptors to cure diseases, for...
|
|
|
US20120252892 |
METHODS FOR TREATING FIBROMYALGIA SYNDROME
The invention is directed to a method of treating fibromyalgia syndrome in a subject, comprising administering a therapeutically effective amount of a carbamoyl compound, or pharmaceutically...
|
|
|
US20120101087 |
Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins
The present invention relates to, in part, novel bisphenol compounds useful for the recognition, attachment and growth of unwanted biologics on natural and manmade surfaces. Another aspect of the...
|
|
|
US20130078291 |
BIO-ADHESIVE AGENT COMPRISING SURFACE-MODIFIED HYDROXYAPATITE AND USE THEREOF
The present invention relates to a bio-adhesive agent comprising a surface-modified hydroxyapatite and its use. More specifically, the present invention relates to a bio-adhesive agent for the...
|
|
|
US20110190251 |
METHOD FOR INHIBITING THE BUILD-UP OF ARTERIAL PLAQUE BY ADMINISTERING FULLERENES
Disclosed herein are methods of inhibiting the build-up of arterial plaque in a subject in need thereof. These methods comprise administering to the subject in need thereof a therapeutically...
|
|
|
US20120000603 |
ADHESIVE
The invention relates to the use of special isocyanate-terminated polyurethane prepolymers in adhesive formulations. Said adhesive formulations can be used in applications wherein a direct or...
|
|
|
US20110105608 |
MODULATORS OF NUCLEAR RECEPTOR CO-REGULATORY PROTEIN BINDING
Disclosed are novel compounds and compositions for inhibition of androgen and estrogen receptor signaling, methods for inhibiting androgen signaling, methods for inhibiting estrogen signaling,...
|
|
|
US20130261133 |
Therapeutic Compounds for Protozoal and Microbial Infections and Cancer
The compounds of the invention exhibit antiprotozoal, antimicrobial, and anticancer properties that are useful for the treatment or prevention of infections or cancer in a patient (e.g., a human)....
|
|
|
US20110091404 |
COMPOSITIONS COMPRISING FRAGRANCE SUBSTANCES AND COMPRISING CETYL NONANOATE AND/OR STEARYL NONANOATE
The invention relates to the use of n-hexadecyl n-nonanoate (CAS number 72934-15-7, hereafter cetyl nonanoate) and n-octadecyl n-nonanoate (CAS number 107647-13-2, hereafter stearyl nonanoate) and...
|
|
|
US20110269689 |
HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
High penetration compositions (HPC) of a parent compound, which are capable of crossing biological barriers with high penetration efficiency. The HPCs are capable of being converted to parent drugs...
|
|
|
US20120088782 |
LPA RECEPTOR ANTAGONIST
A compound of the general formula (I): (wherein the symbols are as defined in the description), or a non-toxic salt thereof. This compound engages in LPA receptor bonding and antagonism and hence...
|
|
|
US20120142958 |
CHEMICAL RECYCLING OF PLA BY HYDROLYSIS
A process for recycling a polymer blend necessarily containing PLA, comprising grinding, compacting, dissolving in a solvent of PLA, removing the undissolved contamining polymers, alcoholysis...
|
|
|
US20110028522 |
FULLERENE THERAPIES FOR INFLAMMATION
Described herein are methods for treating inflammatory disorders. The methods comprise administering to a subject in need thereof a therapeutically effective amount of a synthetically modified...
|
|
|
US20130261094 |
TUNABLE, BIODEGRADABLE LINKER MOLECULES FOR TRANSIENT CONJUGATION OF COMPONENTS IN DRUG DELIVERY SYSTEMS, AND DRUG DELIVERY SYSTEMS PREPARED THEREWITH
The present invention relates to a particular class of biodegradable linkers, ensuring transiently stable conjugation of building blocks and/or bioactive compounds into drug delivery systems (DDS),...
|
|
|
US20120302637 |
Methods of Treating Tachycardia and/or Controlling Heart Rate While Minimizing and/or Controlling Hypotension
A method of treating tachycardia while minimizing and/or controlling hypotension associated with such treatment includes administering a therapeutically effective amount of a pharmaceutical...
|
|
|
US20120142531 |
Coated Dehydrated Microorganisms with Enhanced Stability and Viability
The present invention relates to coated dehydrated microorganisms comprising a dehydrated microorganism surrounded by at least one coating, said coating comprising by dry weight at least 25% of...
|
|
|
US20110118686 |
SUBSTRATE WITH ADHERENCE FOR FECES AND MENSES
A composition applied on the body facing surface of an absorbent article such as a diaper, training pant, adult incontinence product, feminine hygiene product, may be used to impart the adherence...
|
|
|
US20110319558 |
METHOD FOR COATING A FLOOR
A method for coating a floor, wherein said method comprises applying an aqueous dispersion comprising polyurethane, an acrylate or a hybride or mixture thereof; drying said coating and subjecting...
|
|
|
US20120029228 |
CHEMICAL RECYCLING OF PLA BY ALCOHOLYSIS
A process for recycling a polymer blend necessarily containing PLA, comprising grinding, compacting, dissolving in a solvent of PLA, removing the undissolved contamining polymers, alcoholysis...
|
|
|
US20120065152 |
PRODRUGS OF GUANFACINE
Prodrugs of guanfacine, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder...
|
|
|
US20130203712 |
METHODS FOR INHIBITING MUSCLE ATROPHY
In one aspect, the invention relates methods for inhibiting or preventing muscle atrophy or increasing muscle mass by providing to a subject in need thereof an effective amount of ursolic acid, a...
|
|
|
US20110184060 |
ORAL DOSAGE FORMS HAVING A HIGH LOADING OF A TRANEXAMIC ACID PRODRUG
Oral dosage forms with a high loading of 4-({[(2-methylpropanoyloxy)ethoxy]carbonylamino}methyl)cyclo
hexanecarboxylic acid are disclosed.
|
|
|
US20120076950 |
CURABLE COMPOSITION FOR IMPRINTS AND PRODUCING METHOD OF POLYMERIZABLE MONOMER FOR IMPRINTS
Provided is a curable composition for imprints excellent in pattern transferability. Disclosed is a curable composition for imprints comprising a polymerizable monomer (A) and a polymerization...
|
|
|
US20110112131 |
Opioid-Ketamine and Norketamine Codrug Combinations for Pain Management
The present invention relates to the field of pain management, and more particularly to synergistic codrugs comprising an opioid and ketamine or norketamine which have been combined to form a...
|
|
|
US20120128770 |
TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE
The present invention relates to 1 or 2 C16-C18 acyl glycerol based compounds which are capable of activating G-protein coupled receptor 119 and thereby stimulate GLP-1 release. Compounds of the...
|
|
|
US20130238118 |
fD
The invention disclosed herein relates to methods and means for allocating, allotting, apportioning, dispensing, distributing, preparing, portioning, meting out and/or otherwise providing,...
|
|
|
US20130202704 |
USE OF MEXIPROSTIL IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE AND/OR OF IRRITABLE BOWEL SYNDROME
The invention relates to the use of mexiprostil in the treatment and/or prevention of inflammatory bowel disease and of irritable bowel syndrome, to the combinations of mexiprostil with other...
|